Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease

Overnight heart rate variability in patients with obstructive sleep apnoea: A time and frequency domain study

(2012) Kaixian Zhu et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

The heart rate story

(2011) C. Ceconi et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women

(2010) Marie Therese Cooney et al.   AMERICAN HEART JOURNAL

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

(2010) Michael Böhm et al.   LANCET

Pathophysiology of Sleep Apnea

(2010) Jerome A. Dempsey et al.   PHYSIOLOGICAL REVIEWS

Heart rate, autonomic markers, and cardiac mortality

(2009) Richard L. Verrier et al.   HEART RHYTHM

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

(2008) Kim Fox et al.   LANCET